Silo Pharma, Inc. quarterly report, Q3 FY2015

SEC Filing Summary: Point Capital, Inc. (10-Q)

Business Context and Reporting Period

This filing is a Quarterly Report (Form 10-Q) for Point Capital, Inc., a closed-end, non-diversified Business Development Company (BDC) regulated under the Investment Company Act of 1940. The report covers the period ended September 30, 2015. The Company's investment objective is to provide current income and capital appreciation by investing in the common stock, preferred stock, warrants, and convertible notes of small and mid-cap companies. As of the reporting date, the Company held 20 portfolio companies, all classified as non-controlled and non-affiliated investments.

Key Financial Metrics

Metric Sept 30, 2015 Dec 31, 2014
Total Assets $2,416,213 $2,771,532
Net Assets $2,015,448 $2,368,978
Cash and Cash Equivalents $779,243 $1,739,520
Investments at Fair Value $1,601,646 $1,008,437
Net Asset Value (NAV) per Share $0.04 $0.05
Investment Income (9 Months) $24,448 $15,918
Operating Expenses (9 Months) $191,829 $221,933
Net Investment Loss (9 Months) $(167,381) $(206,015)
Net Realized Gain/Loss (9 Months) $(54,515) $104,260
Net Unrealized Depreciation (9 Months) $(194,391) $(228,221)
Total Net Decrease in Net Assets (9 Months) $(416,287) $(329,976)

Liquidity and Debt: The Company reported no long-term debt. Liabilities consisted primarily of accounts payable ($765) and $400,000 in Redeemable Series A Convertible Preferred Stock. Cash decreased by approximately $960,000 during the nine-month period, primarily due to investment purchases of $1.2 million.

Material Changes vs. Prior Period

  • Portfolio Growth: Investments at fair value increased by approximately 59% from $1.01 million to $1.60 million, driven by new investments in MultiMedia Platforms, Home Bistro, Accelerize, ID Global Solutions, and others.
  • Operating Expenses: Total operating expenses for the nine months ended Sept 30, 2015, decreased by $30,104 compared to the prior year. This was due to a significant reduction in stock-based consulting fees ($112,500 decrease) and other consulting fees, partially offset by an increase in compensation expense ($74,370) and professional fees.
  • Realized Gains/Losses: The Company shifted from a net realized gain of $104,260 in the prior year to a net realized loss of $54,515 in the current period.
  • Unrealized Depreciation: The portfolio experienced significant unrealized depreciation of $194,391 for the nine months ended Sept 30, 2015, compared to $228,221 in the prior year. The cost basis of the portfolio ($1.95 million) exceeded the fair value ($1.60 million).

Outlook, Risks, and Unusual Items

  • SEC Inquiry: In Item 5 (Other Information), the Company disclosed that it was contacted by the SEC regarding potential non-compliance with certain provisions of the Investment Company Act of 1940. The Company responded to the issues, and as of the filing date, there had been no further communication.
  • Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of September 30, 2015. Significant weaknesses in internal control over financial reporting were identified, specifically regarding the segregation of duties and timely decision-making for disclosures.
  • Liquidity: Management believes existing cash ($779,243) is sufficient to meet working capital requirements for at least 12 months.
  • Subsequent Events: In November 2015, the Company sold marketable securities for net proceeds of approximately $67,600.
  • Valuation Risks: A significant portion of the portfolio (Level 3 assets totaling $865,377) relies on unobservable inputs and fair value determinations made in good faith by the Board, which may differ from values realized in a forced liquidation.

Investor Verification Checklist

  • SEC Compliance Status: Verify the current status of the SEC inquiry regarding Investment Company Act compliance and any potential penalties or remediation plans.
  • Internal Control Remediation: Review the specific steps taken to address the ineffective disclosure controls and significant weaknesses in financial reporting.
  • Portfolio Valuation: Scrutinize the fair value assumptions (Level 3 inputs) for illiquid securities, particularly the discounts for lack of marketability (DLOM) and price multiples used.
  • Cash Burn Rate: Monitor the cash balance relative to operating expenses, given the net investment loss and lack of significant financing activities in the current period.
  • Preferred Stock Triggers: Review the terms of the $400,000 Redeemable Series A Preferred Stock to understand potential redemption triggers that could impact liquidity.